Tanabe Pharma Factory Co., Ltd.

During pharmaceutical manufacturing, line-scan hyperspectral imaging enables us to collect several electromagnetic spectra at each pixel in a two-dimensional plane for each tablet. The present study quantitatively determines two independent values of the active pharmaceutical ingredient (API) content in a tablet and the amount of coating on a surface of the same tablet simultaneously; the process is visualized by means of a near-infrared hyperspectral imaging (NIR-HSI) system combined with multivariate data analysis at a typical manufacturing speed of 4,000 tablets per minute. The API content and the amount of coating were controlled to be in the range 80-120% and 0-7 mg, respectively. The results of the cross validation of regression models demonstrated a coefficient of determination (R²) of 0.942, a root-mean-square error of cross validation (RMSECV) of 3.48% for the API content, an R² of 0.939, and an RMSECV of 0.46 mg for the amount of coating. These results demonstrated that the API content in a tablet as well as the amount of coating on the surface of the same tablet can be simultaneously determined with sufficient accuracy. This technique is practically applicable to process analytical technology in pharmaceutical manufacturing.

Helicobacter pylori (Hp) infection is related to the pathogenesis of chronic gastric disorders and extragastric diseases. Here, we examined the anorexigenic and anxiogenic effects of Hp vacuolating cytotoxin A (VacA) through activation of hypothalamic urocortin1 (Ucn1). VacA was detected in the hypothalamus after peripheral administration and increased Ucn1 mRNA expression and c-Fos-positive cells in the hypothalamus but not in the nucleus tractus solitarius. c-Fos and Ucn1-double positive cells were detected. CRF1 and CRF2 receptor antagonists suppressed VacA-induced anxiety and anorexia, respectively. VacA activated single paraventricular nucleus neurons and A7r5 cells; this activation was inhibited by phospholipase C (PLC) and protein kinase C (PKC) inhibitors. VacA causes anorexia and anxiety through the intracellular PLC-PKC pathway, migrates across the blood-brain barrier, and activates the Ucn1-CRF receptor axis.